Fundz

Diasome Pharmaceuticals, Inc. reported raising $4.35 Million in an initial SEC Form D filing, from an offering of $8 Million

PRIVATEJan 17, 2017$4.3M of $8M raised

Amount Raised

$4.35 Million

$4.35 Million sold, per SEC Form D (first sale Jan 17, 2017)

Round Type

Seed

ClevelandBiotechnologyHealthcare

Quick answer

Diasome Pharmaceuticals raised $4.35 Million in a Seed round, dated January 17, 2017. Diasome Pharmaceuticals is based in Cleveland, Ohio, United States.

How much did Diasome Pharmaceuticals raise?
Diasome Pharmaceuticals raised $4.35 Million in a Seed round on January 17, 2017.
What does Diasome Pharmaceuticals do?
Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases.
Where is Diasome Pharmaceuticals based and how big is it?
Diasome Pharmaceuticals is based in Cleveland, Ohio, United States.
Who are the decision-makers at Diasome Pharmaceuticals?
Fundz holds 1 contact at Diasome Pharmaceuticals, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Diasome Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • XTL Biopharmaceuticals Ltd raised $2.5M (Seed) on March 1, 2017.
  • PharmacoPhotonics, Inc. raised $3M (Seed) on February 23, 2017.
  • Istari Oncology, Inc. raised $4M (Seed) on February 15, 2017.
  • IRulya Therapeutics Inc. raised $7.6M on February 14, 2017.
  • SiteOne Therapeutics raised $15M on February 14, 2017.
  • AIM ImmunoTech raised $18K (Pre-Seed) on February 13, 2017.

Who to call at Diasome Pharmaceuticals, and when

A new round usually means Diasome Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Diasome Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Diasome Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Diasome Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Diasome Pharmaceuticals

Location

10000 CEDAR AVENUE

Cleveland, Ohio, United States

About

Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases. Diasome's Hepatocyte Targeting Platform reestablishes hepatocyte function, addressing the root cause of dysregulations central to major metabolic diseases such as diabetes, obesity, and dyslipidemia. Diasome aims to deliver superior patient outcomes and enhanced disease management by leveraging the hepatocyte's natural regulatory functions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Diasome Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRobert G., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Diasome Pharmaceuticals's next move

See what Strategic adds

Diasome Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.